Regulator of g protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor

Molecular Endocrinology

Volumn 25, Issue 5, 2011, Pages 867-876

  Koh, James ^a   Dar, Moahad ^b   Untch, Brian R ^a   Dixit, Darshana ^a   Shi, Yuhong ^a   Yang, Zhao ^a   Adam, Mohamed Abdelgadir ^a   Dressman, Holly ^a   Wang, Xiaojuan ^a   Gesty Palmer, Diane ^a   Marks, Jeffrey R ^a   Spurney, Robert ^a   Druey, Kirk M ^c   Olson Jr , John A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; G PROTEIN SIGNALING 5; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RGS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; DESENSITIZATION; EMBRYO; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION;

ADENOMA; ANIMALS; CALCIUM; CALCIUM GLUCONATE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; RECEPTORS, CALCIUM-SENSING; RGS PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

MUS;

EID: 79955748231     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0277     Document Type: Article

References (30)

1. Brown EM 1993 Mechanisms underlying the regulation of para- thyroid hormone secretion in vivo and in vitro. Curr Opin Nephrol Hypertens 2:541-551
2. Brown EM 1983 Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56:572-581
3. Mallya SM, Arnold A 2000 Cyclin D1 in parathyroid disease. Front Biosci 5: D367-D371
4. Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y, Saucier K. 2002 Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N30-N36
5. Corbetta S, Mantovani G, Lania A, Borgato S, Vicentini L, Beretta E, Faglia G, Di Blasio AM, Spada A 2000 Calcium-sensing receptor expression and signalling in human parathyroid adenomas and pri- mary hyperplasia. Clin Endocrinol (Oxf) 52:339-348
6. Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, Drüeke TB 1997 Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336
7. Kifor O, Moore Jr FD, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM 1996 Reduced immunostaining for the extracellular Ca2 sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606
8. Farnebo F, Hoog A, Sandelin K, Larsson C, Farnebo LO 1998 Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. Surgery 124:1094-1098; discussion 1098-1099
9. Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C, Farnebo LO 1997 Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82: 3481- 3486
10. Morrison C, Farrar W, Kneile J, Williams N, Liu-Stratton Y, Bakaletz A, Aldred MA, Eng C 2004 Molecular classification of parathyroid neoplasia by gene expression profiling. Am J Pathol 165:565-576
11. Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, Sethuraman A, van de Rijn M, Botstein D, Brown PO, Pollack JR 2005 A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6:R22
12. Rosen JE, Costouros NG, Lorang D, Burns AL, Alexander HR, Skarulis MC, Cochran C, Pingpank JF, Marx SJ, Spiegel AM, Li- butti SK 2005 Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas. Ann Surg Oncol 12:412-416
13. Cho H, Park C, Hwang IY, Han SB, Schimel D, Despres D, Kehrl JH 2008 Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28:2590-2597
14. Lee MJ, Tasaki T, Moroi K, An JY, Kimura S, Davydov IV, Kwon YT 2005 RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc Natl Acad Sci USA 102:15030-15035
15. Bodenstein J, Sunahara RK, Neubig RR 2007 N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol 71:1040-1050
16. Hendriks-Balk MC, Peters SL, Michel MC, Alewijnse AE 2008 Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol 585:278-291
17. Zhuang X, Adipietro KA, Datta S, Northup JK, Ray K 2010 Rab1 small GTP-binding protein regulates cell surface trafficking of the human calcium sensing receptor. Endocrinology 151:5114-5123
18. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, Brown EM 2001 Regulation of MAP kinase by calcium-sensing receptor in bovine arathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 80:F291-F302
19. MacLeod RJ, Chattopadhyay N, Brown EM 2003 PTHrP stimu-lated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 284:E435-E442
20. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG 1994 Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108-1112
21. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115-1122
22. Hough TA, Bogani D, Cheeseman MT, Favor J, Nesbit MA, Thak- ker RV, Lyon MF 2004 Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 101:13566-13571
23. Fryer RM, Segreti JA, Widomski DL, Franklin PH, Banfor PN, Koch KA, Nakane M, Wu-Wong JR, Cox BF, Reinhart GA 2007 Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet. J Pharmacol Exp Ther 323: 217-226
24. Bansal G, Druey KM, Xie Z 2007 R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 116:473-495
25. Abramow Newerly M, Ming H, Chidiac P 2006 Modulation of subfamily B/R4 RGS protein function by 14-3-3 proteins. Cell Signal 18:2209-2222
26. Pi M, Spurney RF, Tu Q, Hinson T, Quarles LD 2002 Calcium- sensing receptor activation of rho involves filamin and -guanine nucleotide exchange factor. Endocrinology 143:3830-3838
27. 2 -sensing receptor activates cytosolic phospholipase A2 via a Gq α-dependent ERK-independent pathway. J Biol Chem 276: 13941-13948
28. Pi M, Oakley RH, Gesty-Palmer D, Cruickshank RD, Spurney RF, Luttrell LM, Quarles LD 2005 β-Arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol En- docrinol 19:1078 1087
29. Spurney RF 1998 Role of C-terminal serines in desensitization and phosphorylation of the mouse thromboxane receptor. J Biol Chem 273:28496-28503
30. Imanishi Y, Hall C, Sablosky M, Brown EM, Arnold A 2002 A new method for in vivo analysis of parathyroid hormone-calcium set point in mice. J Bone Miner Res 17:1656-1661